Buy ANDEXXA 200 mg/20mL andexanet alfa

ANDEXXA 200 mg/20mL is a lyophilized powder for solution, used for specific medical conditions. This product is manufactured by AstraZeneca Pharmaceuticals LP in the USA.

Strength

200 mg/20mL

Pack Size

5 VIAL, SINGLE-USE in 1 CARTON (0310-3200-05) / 20 mL in 1 VIAL, SINGLE-USE (0310-3200-01)

Manufacturer / TM Owner

AstraZeneca Pharmaceuticals LP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

ANDEXXA 200 mg/20mL is primarily used to reverse the effects of certain anticoagulants. It is administered intravenously and is designed to address specific medical needs related to blood clotting. The drug is often considered in situations where rapid reversal of anticoagulation is required.

Side Effects

ANDEXXA 200 mg/20mL may cause common effects such as headache, nausea, and flushing. These effects can vary from person to person and are not experienced by everyone who uses the medication. It is important to monitor for any adverse reactions and consult a healthcare provider if necessary.

Precautions & Warnings

ANDEXXA 200 mg/20mL should be handled with care, ensuring proper storage and preparation. It is crucial to follow the instructions provided by healthcare professionals for safe administration. Patients with certain medical conditions or allergies should inform their healthcare provider before using this medication.

Avoid Interactions

ANDEXXA 200 mg/20mL may interact with other medications, particularly those that affect blood clotting. It is important to inform healthcare providers about all medications being taken to avoid potential interactions. Alcohol and certain foods may also affect the drug's efficacy.

References

Frequently Asked Questions

ANDEXXA 200 mg/20mL is used to reverse the effects of certain anticoagulants, particularly in situations requiring rapid reversal of anticoagulation.

ANDEXXA 200 mg/20mL is administered intravenously after reconstitution of the lyophilized powder.

Common effects may include headache, nausea, and flushing, though not everyone experiences these effects.

Yes, it is important to follow healthcare provider instructions for safe administration and to inform them of any medical conditions or allergies.

Yes, it may interact with other medications that affect blood clotting, so it is important to inform healthcare providers about all medications being taken.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.